nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Renal failure chronic—Ergocalciferol—osteoporosis	0.037	0.0645	CcSEcCtD
Pralatrexate—Renal failure chronic—Calcitriol—osteoporosis	0.0223	0.0389	CcSEcCtD
Pralatrexate—Renal failure chronic—Zoledronate—osteoporosis	0.0163	0.0285	CcSEcCtD
Pralatrexate—Pemetrexed—ATIC—osteoporosis	0.0117	0.35	CrCbGaD
Pralatrexate—Tetrahydrofolic acid—ATIC—osteoporosis	0.00942	0.282	CrCbGaD
Pralatrexate—FPGS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00838	0.0219	CbGpPWpGaD
Pralatrexate—Night sweats—Zoledronate—osteoporosis	0.00814	0.0142	CcSEcCtD
Pralatrexate—Neoplasm malignant—Estropipate—osteoporosis	0.0075	0.0131	CcSEcCtD
Pralatrexate—Neoplasm malignant—Raloxifene—osteoporosis	0.00726	0.0127	CcSEcCtD
Pralatrexate—Neoplasm malignant—Calcitriol—osteoporosis	0.00704	0.0123	CcSEcCtD
Pralatrexate—Methotrexate—ATIC—osteoporosis	0.00644	0.193	CrCbGaD
Pralatrexate—SLC19A1—Folate Metabolism—SOD2—osteoporosis	0.00643	0.0168	CbGpPWpGaD
Pralatrexate—Night sweats—Estradiol—osteoporosis	0.00627	0.0109	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—GPX1—osteoporosis	0.00614	0.016	CbGpPWpGaD
Pralatrexate—TYMS—Nucleotide metabolism—PNP—osteoporosis	0.00587	0.0153	CbGpPWpGaD
Pralatrexate—TYMS—Nucleotide metabolism—ATIC—osteoporosis	0.00587	0.0153	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—MTHFR—osteoporosis	0.00566	0.0148	CbGpPWpGaD
Pralatrexate—Neoplasm malignant—Pamidronate—osteoporosis	0.00563	0.00983	CcSEcCtD
Pralatrexate—TYMS—Circadian rythm related genes—ID4—osteoporosis	0.00524	0.0137	CbGpPWpGaD
Pralatrexate—Neoplasm malignant—Zoledronate—osteoporosis	0.00515	0.00898	CcSEcCtD
Pralatrexate—Pharyngolaryngeal pain—Estradiol—osteoporosis	0.00502	0.00875	CcSEcCtD
Pralatrexate—Laryngeal pain—Estradiol—osteoporosis	0.00497	0.00867	CcSEcCtD
Pralatrexate—Neoplasm malignant—Conjugated Estrogens—osteoporosis	0.00496	0.00864	CcSEcCtD
Pralatrexate—Pain in extremity—Estropipate—osteoporosis	0.00465	0.00811	CcSEcCtD
Pralatrexate—TYMS—Levorphanol—Estradiol—osteoporosis	0.00461	0.469	CbGdCrCtD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.00454	0.0118	CbGpPWpGaD
Pralatrexate—Pain in extremity—Ibandronate—osteoporosis	0.00446	0.00778	CcSEcCtD
Pralatrexate—Pancytopenia—Etidronic acid—osteoporosis	0.00441	0.00769	CcSEcCtD
Pralatrexate—Pain in extremity—Calcitriol—osteoporosis	0.00436	0.00761	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Alendronate—osteoporosis	0.00412	0.00719	CcSEcCtD
Pralatrexate—Dehydration—Calcitriol—osteoporosis	0.00406	0.00708	CcSEcCtD
Pralatrexate—Anaemia—Ergocalciferol—osteoporosis	0.00402	0.00702	CcSEcCtD
Pralatrexate—Oedema—Calcium Acetate—osteoporosis	0.00402	0.00702	CcSEcCtD
Pralatrexate—DHFR—One Carbon Metabolism—MTHFR—osteoporosis	0.00399	0.0104	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.00397	0.0104	CbGpPWpGaD
Pralatrexate—Neoplasm malignant—Estradiol—osteoporosis	0.00397	0.00692	CcSEcCtD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.00386	0.0101	CbGpPWpGaD
Pralatrexate—Anorexia—Calcium Acetate—osteoporosis	0.00383	0.00669	CcSEcCtD
Pralatrexate—Pain in extremity—Ethinyl Estradiol—osteoporosis	0.00377	0.00657	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Estropipate—osteoporosis	0.00373	0.00651	CcSEcCtD
Pralatrexate—Pain in extremity—Risedronate—osteoporosis	0.00367	0.00641	CcSEcCtD
Pralatrexate—Sepsis—Conjugated Estrogens—osteoporosis	0.00367	0.0064	CcSEcCtD
Pralatrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00359	0.00936	CbGpPWpGaD
Pralatrexate—Upper respiratory tract infection—Ibandronate—osteoporosis	0.00358	0.00625	CcSEcCtD
Pralatrexate—DHFR—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.0035	0.00913	CbGpPWpGaD
Pralatrexate—Decreased appetite—Calcium Acetate—osteoporosis	0.0035	0.0061	CcSEcCtD
Pralatrexate—TYMS—One Carbon Metabolism—MTHFR—osteoporosis	0.00349	0.00909	CbGpPWpGaD
Pralatrexate—Constipation—Calcium Acetate—osteoporosis	0.00344	0.006	CcSEcCtD
Pralatrexate—Liver function test abnormal—Risedronate—osteoporosis	0.00339	0.00592	CcSEcCtD
Pralatrexate—Anorexia—Ergocalciferol—osteoporosis	0.00339	0.00591	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL1B—osteoporosis	0.00336	0.00877	CbGpPWpGaD
Pralatrexate—Liver function test abnormal—Pamidronate—osteoporosis	0.00322	0.00562	CcSEcCtD
Pralatrexate—Pain in extremity—Zoledronate—osteoporosis	0.00319	0.00556	CcSEcCtD
Pralatrexate—Hypokalaemia—Pamidronate—osteoporosis	0.00318	0.00554	CcSEcCtD
Pralatrexate—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00313	0.00817	CbGpPWpGaD
Pralatrexate—Decreased appetite—Ergocalciferol—osteoporosis	0.00309	0.00539	CcSEcCtD
Pralatrexate—Pain in extremity—Conjugated Estrogens—osteoporosis	0.00307	0.00536	CcSEcCtD
Pralatrexate—TYMS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00306	0.00797	CbGpPWpGaD
Pralatrexate—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.00304	0.309	CbGdCrCtD
Pralatrexate—Constipation—Ergocalciferol—osteoporosis	0.00304	0.0053	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Ethinyl Estradiol—osteoporosis	0.00303	0.00528	CcSEcCtD
Pralatrexate—Anaemia—Etidronic acid—osteoporosis	0.00299	0.00522	CcSEcCtD
Pralatrexate—Dehydration—Zoledronate—osteoporosis	0.00297	0.00517	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Risedronate—osteoporosis	0.00295	0.00515	CcSEcCtD
Pralatrexate—Hypokalaemia—Zoledronate—osteoporosis	0.0029	0.00506	CcSEcCtD
Pralatrexate—Leukopenia—Etidronic acid—osteoporosis	0.0029	0.00505	CcSEcCtD
Pralatrexate—Asthenia—Calcium Acetate—osteoporosis	0.00289	0.00503	CcSEcCtD
Pralatrexate—Dehydration—Conjugated Estrogens—osteoporosis	0.00286	0.00498	CcSEcCtD
Pralatrexate—Pruritus—Calcium Acetate—osteoporosis	0.00285	0.00496	CcSEcCtD
Pralatrexate—Neutropenia—Pamidronate—osteoporosis	0.00282	0.00492	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Pamidronate—osteoporosis	0.00281	0.00489	CcSEcCtD
Pralatrexate—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.0028	0.00488	CcSEcCtD
Pralatrexate—Diarrhoea—Calcium Acetate—osteoporosis	0.00275	0.0048	CcSEcCtD
Pralatrexate—Back pain—Estropipate—osteoporosis	0.00271	0.00472	CcSEcCtD
Pralatrexate—Pancytopenia—Zoledronate—osteoporosis	0.00262	0.00457	CcSEcCtD
Pralatrexate—Back pain—Ibandronate—osteoporosis	0.0026	0.00453	CcSEcCtD
Pralatrexate—Neutropenia—Zoledronate—osteoporosis	0.00258	0.0045	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Zoledronate—osteoporosis	0.00256	0.00447	CcSEcCtD
Pralatrexate—Vomiting—Calcium Acetate—osteoporosis	0.00256	0.00446	CcSEcCtD
Pralatrexate—Asthenia—Ergocalciferol—osteoporosis	0.00255	0.00445	CcSEcCtD
Pralatrexate—Anaemia—Alendronate—osteoporosis	0.00255	0.00445	CcSEcCtD
Pralatrexate—Anaemia—Ibandronate—osteoporosis	0.00248	0.00433	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.00247	0.0043	CcSEcCtD
Pralatrexate—Pain in extremity—Estradiol—osteoporosis	0.00246	0.00429	CcSEcCtD
Pralatrexate—Cough—Estropipate—osteoporosis	0.00244	0.00426	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—TNF—osteoporosis	0.00244	0.00636	CbGpPWpGaD
Pralatrexate—Nausea—Calcium Acetate—osteoporosis	0.00239	0.00417	CcSEcCtD
Pralatrexate—SLC19A1—Disease—PKM—osteoporosis	0.00237	0.00618	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SOST—osteoporosis	0.00237	0.00618	CbGpPWpGaD
Pralatrexate—Cough—Raloxifene—osteoporosis	0.00237	0.00413	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—SOD2—osteoporosis	0.00229	0.00596	CbGpPWpGaD
Pralatrexate—Oedema—Estropipate—osteoporosis	0.00228	0.00399	CcSEcCtD
Pralatrexate—Liver function test abnormal—Estradiol—osteoporosis	0.00227	0.00396	CcSEcCtD
Pralatrexate—Constipation—Etidronic acid—osteoporosis	0.00226	0.00394	CcSEcCtD
Pralatrexate—SLC19A1—Disease—PGLS—osteoporosis	0.00225	0.00586	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ANTXR2—osteoporosis	0.00225	0.00586	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—PSMA2—osteoporosis	0.00221	0.00576	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—PSMA5—osteoporosis	0.00221	0.00576	CbGpPWpGaD
Pralatrexate—Back pain—Ethinyl Estradiol—osteoporosis	0.00219	0.00383	CcSEcCtD
Pralatrexate—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00218	0.222	CbGdCrCtD
Pralatrexate—DHFR—Folate Metabolism—GPX1—osteoporosis	0.00218	0.00568	CbGpPWpGaD
Pralatrexate—Tetrahydrofolic acid—MTHFR—osteoporosis	0.00218	0.0652	CrCbGaD
Pralatrexate—Folic Acid—MTHFR—osteoporosis	0.00218	0.0652	CrCbGaD
Pralatrexate—Thrombocytopenia—Raloxifene—osteoporosis	0.00217	0.00378	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00216	0.00377	CcSEcCtD
Pralatrexate—Back pain—Risedronate—osteoporosis	0.00214	0.00373	CcSEcCtD
Pralatrexate—Nausea—Ergocalciferol—osteoporosis	0.00211	0.00368	CcSEcCtD
Pralatrexate—Abdominal pain—Etidronic acid—osteoporosis	0.00209	0.00364	CcSEcCtD
Pralatrexate—Anaemia—Risedronate—osteoporosis	0.00204	0.00357	CcSEcCtD
Pralatrexate—Anorexia—Calcitriol—osteoporosis	0.00204	0.00357	CcSEcCtD
Pralatrexate—Back pain—Pamidronate—osteoporosis	0.00203	0.00355	CcSEcCtD
Pralatrexate—FPGS—Disease—SOST—osteoporosis	0.00202	0.00526	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PKM—osteoporosis	0.00202	0.00526	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—MTHFR—osteoporosis	0.00201	0.00525	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—FDPS—osteoporosis	0.00199	0.00518	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PKM—osteoporosis	0.00199	0.00518	CbGpPWpGaD
Pralatrexate—Cough—Ethinyl Estradiol—osteoporosis	0.00198	0.00345	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Estradiol—osteoporosis	0.00197	0.00344	CcSEcCtD
Pralatrexate—Fatigue—Estropipate—osteoporosis	0.00197	0.00344	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL6—osteoporosis	0.00197	0.00513	CbGpPWpGaD
Pralatrexate—Constipation—Estropipate—osteoporosis	0.00195	0.00341	CcSEcCtD
Pralatrexate—Anaemia—Pamidronate—osteoporosis	0.00194	0.00339	CcSEcCtD
Pralatrexate—Cough—Risedronate—osteoporosis	0.00193	0.00337	CcSEcCtD
Pralatrexate—TYMS—G1/S Transition—PSMA5—osteoporosis	0.00193	0.00503	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—PSMA2—osteoporosis	0.00193	0.00503	CbGpPWpGaD
Pralatrexate—Constipation—Alendronate—osteoporosis	0.00192	0.00336	CcSEcCtD
Pralatrexate—SLC19A1—Disease—GSN—osteoporosis	0.00191	0.00498	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ANTXR2—osteoporosis	0.00191	0.00498	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PGLS—osteoporosis	0.00191	0.00498	CbGpPWpGaD
Pralatrexate—Decreased appetite—Ibandronate—osteoporosis	0.0019	0.00332	CcSEcCtD
Pralatrexate—Fatigue—Ibandronate—osteoporosis	0.00189	0.00329	CcSEcCtD
Pralatrexate—Leukopenia—Pamidronate—osteoporosis	0.00188	0.00328	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—GPD2—osteoporosis	0.00188	0.00491	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PGLS—osteoporosis	0.00188	0.00491	CbGpPWpGaD
Pralatrexate—Constipation—Ibandronate—osteoporosis	0.00187	0.00327	CcSEcCtD
Pralatrexate—Pruritus—Etidronic acid—osteoporosis	0.00187	0.00326	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Estropipate—osteoporosis	0.00187	0.00326	CcSEcCtD
Pralatrexate—Decreased appetite—Calcitriol—osteoporosis	0.00186	0.00325	CcSEcCtD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00186	0.00485	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00186	0.00485	CbGpPWpGaD
Pralatrexate—Back pain—Zoledronate—osteoporosis	0.00186	0.00324	CcSEcCtD
Pralatrexate—Oedema—Ethinyl Estradiol—osteoporosis	0.00185	0.00323	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Alendronate—osteoporosis	0.00184	0.00321	CcSEcCtD
Pralatrexate—Cough—Pamidronate—osteoporosis	0.00184	0.0032	CcSEcCtD
Pralatrexate—Constipation—Calcitriol—osteoporosis	0.00183	0.0032	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Raloxifene—osteoporosis	0.00181	0.00316	CcSEcCtD
Pralatrexate—Diarrhoea—Etidronic acid—osteoporosis	0.00181	0.00315	CcSEcCtD
Pralatrexate—Abdominal pain—Estropipate—osteoporosis	0.00181	0.00315	CcSEcCtD
Pralatrexate—Body temperature increased—Estropipate—osteoporosis	0.00181	0.00315	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Ibandronate—osteoporosis	0.00179	0.00313	CcSEcCtD
Pralatrexate—Back pain—Conjugated Estrogens—osteoporosis	0.00179	0.00312	CcSEcCtD
Pralatrexate—Epistaxis—Estradiol—osteoporosis	0.00179	0.00312	CcSEcCtD
Pralatrexate—Abdominal pain—Alendronate—osteoporosis	0.00178	0.0031	CcSEcCtD
Pralatrexate—Body temperature increased—Alendronate—osteoporosis	0.00178	0.0031	CcSEcCtD
Pralatrexate—Anaemia—Zoledronate—osteoporosis	0.00178	0.0031	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Calcitriol—osteoporosis	0.00175	0.00306	CcSEcCtD
Pralatrexate—Abdominal pain—Raloxifene—osteoporosis	0.00175	0.00305	CcSEcCtD
Pralatrexate—Body temperature increased—Raloxifene—osteoporosis	0.00175	0.00305	CcSEcCtD
Pralatrexate—Abdominal pain—Ibandronate—osteoporosis	0.00173	0.00302	CcSEcCtD
Pralatrexate—Body temperature increased—Ibandronate—osteoporosis	0.00173	0.00302	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—PNP—osteoporosis	0.00172	0.00449	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ATIC—osteoporosis	0.00172	0.00449	CbGpPWpGaD
Pralatrexate—Leukopenia—Zoledronate—osteoporosis	0.00172	0.003	CcSEcCtD
Pralatrexate—Oedema—Pamidronate—osteoporosis	0.00172	0.00299	CcSEcCtD
Pralatrexate—Body temperature increased—Calcitriol—osteoporosis	0.0017	0.00296	CcSEcCtD
Pralatrexate—Abdominal pain—Calcitriol—osteoporosis	0.0017	0.00296	CcSEcCtD
Pralatrexate—FPGS—Metabolism—PKM—osteoporosis	0.00169	0.0044	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—FDPS—osteoporosis	0.00169	0.0044	CbGpPWpGaD
Pralatrexate—Thrombocytopenia—Pamidronate—osteoporosis	0.00168	0.00293	CcSEcCtD
Pralatrexate—Vomiting—Etidronic acid—osteoporosis	0.00168	0.00293	CcSEcCtD
Pralatrexate—Cough—Zoledronate—osteoporosis	0.00168	0.00292	CcSEcCtD
Pralatrexate—Tachycardia—Pamidronate—osteoporosis	0.00168	0.00292	CcSEcCtD
Pralatrexate—Rash—Etidronic acid—osteoporosis	0.00167	0.0029	CcSEcCtD
Pralatrexate—TYMS—Nucleotide metabolism—GPX1—osteoporosis	0.00166	0.00434	CbGpPWpGaD
Pralatrexate—Dermatitis—Etidronic acid—osteoporosis	0.00166	0.0029	CcSEcCtD
Pralatrexate—SLC19A1—Disease—LRP5—osteoporosis	0.00166	0.00433	CbGpPWpGaD
Pralatrexate—Asthenia—Estropipate—osteoporosis	0.00164	0.00286	CcSEcCtD
Pralatrexate—Anorexia—Pamidronate—osteoporosis	0.00164	0.00285	CcSEcCtD
Pralatrexate—FPGS—Disease—GSN—osteoporosis	0.00162	0.00424	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00162	0.00424	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00162	0.00424	CbGpPWpGaD
Pralatrexate—Pruritus—Estropipate—osteoporosis	0.00162	0.00282	CcSEcCtD
Pralatrexate—Asthenia—Alendronate—osteoporosis	0.00161	0.00282	CcSEcCtD
Pralatrexate—Cough—Conjugated Estrogens—osteoporosis	0.00161	0.00282	CcSEcCtD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.00161	0.00421	CbGpPWpGaD
Pralatrexate—Dyspnoea—Risedronate—osteoporosis	0.00161	0.00281	CcSEcCtD
Pralatrexate—FPGS—Metabolism—GPD2—osteoporosis	0.0016	0.00417	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PGLS—osteoporosis	0.0016	0.00417	CbGpPWpGaD
Pralatrexate—Fatigue—Ethinyl Estradiol—osteoporosis	0.0016	0.00278	CcSEcCtD
Pralatrexate—Pruritus—Alendronate—osteoporosis	0.00159	0.00278	CcSEcCtD
Pralatrexate—SLC19A1—Disease—LRP6—osteoporosis	0.00159	0.00415	CbGpPWpGaD
Pralatrexate—Constipation—Ethinyl Estradiol—osteoporosis	0.00158	0.00276	CcSEcCtD
Pralatrexate—Asthenia—Ibandronate—osteoporosis	0.00157	0.00274	CcSEcCtD
Pralatrexate—Nausea—Etidronic acid—osteoporosis	0.00157	0.00274	CcSEcCtD
Pralatrexate—Oedema—Zoledronate—osteoporosis	0.00157	0.00273	CcSEcCtD
Pralatrexate—Diarrhoea—Estropipate—osteoporosis	0.00156	0.00273	CcSEcCtD
Pralatrexate—Fatigue—Risedronate—osteoporosis	0.00156	0.00272	CcSEcCtD
Pralatrexate—Pruritus—Ibandronate—osteoporosis	0.00155	0.0027	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00154	0.00403	CbGpPWpGaD
Pralatrexate—Constipation—Risedronate—osteoporosis	0.00154	0.00269	CcSEcCtD
Pralatrexate—Diarrhoea—Alendronate—osteoporosis	0.00154	0.00269	CcSEcCtD
Pralatrexate—Asthenia—Calcitriol—osteoporosis	0.00154	0.00268	CcSEcCtD
Pralatrexate—Thrombocytopenia—Zoledronate—osteoporosis	0.00154	0.00268	CcSEcCtD
Pralatrexate—Dyspnoea—Pamidronate—osteoporosis	0.00153	0.00267	CcSEcCtD
Pralatrexate—Tachycardia—Zoledronate—osteoporosis	0.00153	0.00267	CcSEcCtD
Pralatrexate—SLC19A1—Disease—RPL24—osteoporosis	0.00153	0.00398	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—LTF—osteoporosis	0.00153	0.00398	CbGpPWpGaD
Pralatrexate—Pruritus—Calcitriol—osteoporosis	0.00152	0.00265	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00151	0.00264	CcSEcCtD
Pralatrexate—Diarrhoea—Raloxifene—osteoporosis	0.00151	0.00264	CcSEcCtD
Pralatrexate—Oedema—Conjugated Estrogens—osteoporosis	0.00151	0.00263	CcSEcCtD
Pralatrexate—Diarrhoea—Ibandronate—osteoporosis	0.0015	0.00261	CcSEcCtD
Pralatrexate—Anorexia—Zoledronate—osteoporosis	0.00149	0.00261	CcSEcCtD
Pralatrexate—Decreased appetite—Pamidronate—osteoporosis	0.00149	0.0026	CcSEcCtD
Pralatrexate—Methotrexate—MTHFR—osteoporosis	0.00149	0.0446	CrCbGaD
Pralatrexate—Fatigue—Pamidronate—osteoporosis	0.00148	0.00258	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Risedronate—osteoporosis	0.00148	0.00258	CcSEcCtD
Pralatrexate—Tachycardia—Conjugated Estrogens—osteoporosis	0.00147	0.00257	CcSEcCtD
Pralatrexate—Constipation—Pamidronate—osteoporosis	0.00147	0.00256	CcSEcCtD
Pralatrexate—Diarrhoea—Calcitriol—osteoporosis	0.00147	0.00256	CcSEcCtD
Pralatrexate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00146	0.00255	CcSEcCtD
Pralatrexate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00146	0.00255	CcSEcCtD
Pralatrexate—FPGS—Metabolism—PNP—osteoporosis	0.00146	0.00382	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—OXCT1—osteoporosis	0.00146	0.00382	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ATIC—osteoporosis	0.00146	0.00382	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CA2—osteoporosis	0.00146	0.00382	CbGpPWpGaD
Pralatrexate—Vomiting—Estropipate—osteoporosis	0.00145	0.00253	CcSEcCtD
Pralatrexate—Rash—Estropipate—osteoporosis	0.00144	0.00251	CcSEcCtD
Pralatrexate—Dermatitis—Estropipate—osteoporosis	0.00144	0.00251	CcSEcCtD
Pralatrexate—Anorexia—Conjugated Estrogens—osteoporosis	0.00144	0.00251	CcSEcCtD
Pralatrexate—Back pain—Estradiol—osteoporosis	0.00143	0.0025	CcSEcCtD
Pralatrexate—Vomiting—Alendronate—osteoporosis	0.00143	0.0025	CcSEcCtD
Pralatrexate—Abdominal pain—Risedronate—osteoporosis	0.00143	0.00249	CcSEcCtD
Pralatrexate—Body temperature increased—Risedronate—osteoporosis	0.00143	0.00249	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—MGLL—osteoporosis	0.00143	0.00372	CbGpPWpGaD
Pralatrexate—Rash—Alendronate—osteoporosis	0.00142	0.00247	CcSEcCtD
Pralatrexate—Dermatitis—Alendronate—osteoporosis	0.00142	0.00247	CcSEcCtD
Pralatrexate—FPGS—Disease—LRP5—osteoporosis	0.00141	0.00369	CbGpPWpGaD
Pralatrexate—Vomiting—Raloxifene—osteoporosis	0.00141	0.00245	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Pamidronate—osteoporosis	0.0014	0.00245	CcSEcCtD
Pralatrexate—Dyspnoea—Zoledronate—osteoporosis	0.0014	0.00244	CcSEcCtD
Pralatrexate—Rash—Raloxifene—osteoporosis	0.0014	0.00243	CcSEcCtD
Pralatrexate—Dermatitis—Raloxifene—osteoporosis	0.00139	0.00243	CcSEcCtD
Pralatrexate—Vomiting—Ibandronate—osteoporosis	0.00139	0.00243	CcSEcCtD
Pralatrexate—Rash—Ibandronate—osteoporosis	0.00138	0.00241	CcSEcCtD
Pralatrexate—Dermatitis—Ibandronate—osteoporosis	0.00138	0.00241	CcSEcCtD
Pralatrexate—Vomiting—Calcitriol—osteoporosis	0.00136	0.00238	CcSEcCtD
Pralatrexate—Decreased appetite—Zoledronate—osteoporosis	0.00136	0.00238	CcSEcCtD
Pralatrexate—Nausea—Estropipate—osteoporosis	0.00136	0.00237	CcSEcCtD
Pralatrexate—Body temperature increased—Pamidronate—osteoporosis	0.00136	0.00237	CcSEcCtD
Pralatrexate—Abdominal pain—Pamidronate—osteoporosis	0.00136	0.00237	CcSEcCtD
Pralatrexate—Rash—Calcitriol—osteoporosis	0.00135	0.00236	CcSEcCtD
Pralatrexate—FPGS—Disease—LRP6—osteoporosis	0.00135	0.00353	CbGpPWpGaD
Pralatrexate—Fatigue—Zoledronate—osteoporosis	0.00135	0.00236	CcSEcCtD
Pralatrexate—Dermatitis—Calcitriol—osteoporosis	0.00135	0.00236	CcSEcCtD
Pralatrexate—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00135	0.00235	CcSEcCtD
Pralatrexate—Constipation—Zoledronate—osteoporosis	0.00134	0.00234	CcSEcCtD
Pralatrexate—Nausea—Alendronate—osteoporosis	0.00134	0.00233	CcSEcCtD
Pralatrexate—Asthenia—Ethinyl Estradiol—osteoporosis	0.00133	0.00232	CcSEcCtD
Pralatrexate—SLC19A1—Disease—ACP5—osteoporosis	0.00132	0.00345	CbGpPWpGaD
Pralatrexate—Nausea—Raloxifene—osteoporosis	0.00131	0.00229	CcSEcCtD
Pralatrexate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00131	0.00229	CcSEcCtD
Pralatrexate—Pruritus—Ethinyl Estradiol—osteoporosis	0.00131	0.00229	CcSEcCtD
Pralatrexate—Fatigue—Conjugated Estrogens—osteoporosis	0.0013	0.00227	CcSEcCtD
Pralatrexate—Nausea—Ibandronate—osteoporosis	0.0013	0.00227	CcSEcCtD
Pralatrexate—FPGS—Disease—RPL24—osteoporosis	0.0013	0.00339	CbGpPWpGaD
Pralatrexate—FPGS—Disease—LTF—osteoporosis	0.0013	0.00339	CbGpPWpGaD
Pralatrexate—Asthenia—Risedronate—osteoporosis	0.0013	0.00226	CcSEcCtD
Pralatrexate—Cough—Estradiol—osteoporosis	0.00129	0.00225	CcSEcCtD
Pralatrexate—Constipation—Conjugated Estrogens—osteoporosis	0.00129	0.00225	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Zoledronate—osteoporosis	0.00128	0.00224	CcSEcCtD
Pralatrexate—Pruritus—Risedronate—osteoporosis	0.00128	0.00223	CcSEcCtD
Pralatrexate—Nausea—Calcitriol—osteoporosis	0.00127	0.00222	CcSEcCtD
Pralatrexate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00127	0.00221	CcSEcCtD
Pralatrexate—FPGS—Metabolism—OXCT1—osteoporosis	0.00124	0.00325	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CA2—osteoporosis	0.00124	0.00325	CbGpPWpGaD
Pralatrexate—Body temperature increased—Zoledronate—osteoporosis	0.00124	0.00216	CcSEcCtD
Pralatrexate—Abdominal pain—Zoledronate—osteoporosis	0.00124	0.00216	CcSEcCtD
Pralatrexate—Diarrhoea—Risedronate—osteoporosis	0.00124	0.00215	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00123	0.00215	CcSEcCtD
Pralatrexate—Asthenia—Pamidronate—osteoporosis	0.00123	0.00215	CcSEcCtD
Pralatrexate—SLC19A1—Disease—TPI1—osteoporosis	0.00123	0.00321	CbGpPWpGaD
Pralatrexate—Pruritus—Pamidronate—osteoporosis	0.00121	0.00212	CcSEcCtD
Pralatrexate—FPGS—Metabolism—MGLL—osteoporosis	0.00121	0.00316	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—IDH2—osteoporosis	0.00121	0.00316	CbGpPWpGaD
Pralatrexate—Oedema—Estradiol—osteoporosis	0.00121	0.00211	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—IL1B—osteoporosis	0.00119	0.00311	CbGpPWpGaD
Pralatrexate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00119	0.00208	CcSEcCtD
Pralatrexate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00119	0.00208	CcSEcCtD
Pralatrexate—Tachycardia—Estradiol—osteoporosis	0.00118	0.00206	CcSEcCtD
Pralatrexate—Vomiting—Ethinyl Estradiol—osteoporosis	0.00118	0.00205	CcSEcCtD
Pralatrexate—Diarrhoea—Pamidronate—osteoporosis	0.00117	0.00205	CcSEcCtD
Pralatrexate—Rash—Ethinyl Estradiol—osteoporosis	0.00117	0.00204	CcSEcCtD
Pralatrexate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00117	0.00203	CcSEcCtD
Pralatrexate—SLC19A1—Disease—P4HB—osteoporosis	0.00116	0.00302	CbGpPWpGaD
Pralatrexate—Vomiting—Risedronate—osteoporosis	0.00115	0.002	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—CYP27A1—osteoporosis	0.00114	0.00297	CbGpPWpGaD
Pralatrexate—Rash—Risedronate—osteoporosis	0.00114	0.00199	CcSEcCtD
Pralatrexate—Dermatitis—Risedronate—osteoporosis	0.00114	0.00198	CcSEcCtD
Pralatrexate—SLC19A1—Disease—GAPDH—osteoporosis	0.00114	0.00296	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ACP5—osteoporosis	0.00113	0.00294	CbGpPWpGaD
Pralatrexate—Asthenia—Zoledronate—osteoporosis	0.00112	0.00196	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—ACP5—osteoporosis	0.00111	0.00289	CbGpPWpGaD
Pralatrexate—Pruritus—Zoledronate—osteoporosis	0.00111	0.00193	CcSEcCtD
Pralatrexate—Nausea—Ethinyl Estradiol—osteoporosis	0.0011	0.00192	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.0011	0.00287	CbGpPWpGaD
Pralatrexate—Vomiting—Pamidronate—osteoporosis	0.00109	0.0019	CcSEcCtD
Pralatrexate—Asthenia—Conjugated Estrogens—osteoporosis	0.00108	0.00189	CcSEcCtD
Pralatrexate—Rash—Pamidronate—osteoporosis	0.00108	0.00189	CcSEcCtD
Pralatrexate—Dermatitis—Pamidronate—osteoporosis	0.00108	0.00189	CcSEcCtD
Pralatrexate—SLC19A1—Disease—NFATC1—osteoporosis	0.00108	0.00282	CbGpPWpGaD
Pralatrexate—Dyspnoea—Estradiol—osteoporosis	0.00108	0.00188	CcSEcCtD
Pralatrexate—Diarrhoea—Zoledronate—osteoporosis	0.00107	0.00187	CcSEcCtD
Pralatrexate—Nausea—Risedronate—osteoporosis	0.00107	0.00187	CcSEcCtD
Pralatrexate—SLC19A1—Disease—DKK1—osteoporosis	0.00107	0.00279	CbGpPWpGaD
Pralatrexate—Pruritus—Conjugated Estrogens—osteoporosis	0.00107	0.00186	CcSEcCtD
Pralatrexate—Decreased appetite—Estradiol—osteoporosis	0.00105	0.00183	CcSEcCtD
Pralatrexate—FPGS—Disease—TPI1—osteoporosis	0.00105	0.00273	CbGpPWpGaD
Pralatrexate—Fatigue—Estradiol—osteoporosis	0.00104	0.00182	CcSEcCtD
Pralatrexate—Constipation—Estradiol—osteoporosis	0.00103	0.0018	CcSEcCtD
Pralatrexate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00103	0.0018	CcSEcCtD
Pralatrexate—SLC19A1—Disease—WNT1—osteoporosis	0.00103	0.00269	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—TPI1—osteoporosis	0.00103	0.00269	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—IDH2—osteoporosis	0.00103	0.00269	CbGpPWpGaD
Pralatrexate—Nausea—Pamidronate—osteoporosis	0.00102	0.00178	CcSEcCtD
Pralatrexate—SLC19A1—Disease—FGA—osteoporosis	0.001	0.00262	CbGpPWpGaD
Pralatrexate—Vomiting—Zoledronate—osteoporosis	0.000997	0.00174	CcSEcCtD
Pralatrexate—Rash—Zoledronate—osteoporosis	0.000989	0.00172	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Estradiol—osteoporosis	0.000988	0.00172	CcSEcCtD
Pralatrexate—Dermatitis—Zoledronate—osteoporosis	0.000988	0.00172	CcSEcCtD
Pralatrexate—FPGS—Disease—P4HB—osteoporosis	0.000984	0.00257	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—P4HB—osteoporosis	0.00097	0.00253	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP27A1—osteoporosis	0.00097	0.00253	CbGpPWpGaD
Pralatrexate—FPGS—Disease—GAPDH—osteoporosis	0.000966	0.00252	CbGpPWpGaD
Pralatrexate—Vomiting—Conjugated Estrogens—osteoporosis	0.00096	0.00167	CcSEcCtD
Pralatrexate—Body temperature increased—Estradiol—osteoporosis	0.000955	0.00167	CcSEcCtD
Pralatrexate—Abdominal pain—Estradiol—osteoporosis	0.000955	0.00167	CcSEcCtD
Pralatrexate—Rash—Conjugated Estrogens—osteoporosis	0.000952	0.00166	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—GAPDH—osteoporosis	0.000952	0.00248	CbGpPWpGaD
Pralatrexate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000951	0.00166	CcSEcCtD
Pralatrexate—FPGS—Metabolism—ACP5—osteoporosis	0.000943	0.00246	CbGpPWpGaD
Pralatrexate—Nausea—Zoledronate—osteoporosis	0.000931	0.00162	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—RAP1A—osteoporosis	0.000927	0.00242	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NFATC1—osteoporosis	0.000918	0.00239	CbGpPWpGaD
Pralatrexate—FPGS—Disease—DKK1—osteoporosis	0.000911	0.00238	CbGpPWpGaD
Pralatrexate—Nausea—Conjugated Estrogens—osteoporosis	0.000897	0.00156	CcSEcCtD
Pralatrexate—SLC19A1—Disease—ENO1—osteoporosis	0.000895	0.00233	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PSMA5—osteoporosis	0.000882	0.0023	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PSMA2—osteoporosis	0.000882	0.0023	CbGpPWpGaD
Pralatrexate—FPGS—Disease—WNT1—osteoporosis	0.000877	0.00229	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—TPI1—osteoporosis	0.000877	0.00229	CbGpPWpGaD
Pralatrexate—Asthenia—Estradiol—osteoporosis	0.000867	0.00151	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—TNF—osteoporosis	0.000866	0.00226	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—MYC—osteoporosis	0.000858	0.00224	CbGpPWpGaD
Pralatrexate—Pruritus—Estradiol—osteoporosis	0.000855	0.00149	CcSEcCtD
Pralatrexate—FPGS—Disease—FGA—osteoporosis	0.000854	0.00223	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PKM—osteoporosis	0.000842	0.0022	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SOST—osteoporosis	0.000842	0.0022	CbGpPWpGaD
Pralatrexate—Diarrhoea—Estradiol—osteoporosis	0.000827	0.00144	CcSEcCtD
Pralatrexate—FPGS—Metabolism—P4HB—osteoporosis	0.000824	0.00215	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CALCA—osteoporosis	0.000822	0.00214	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GAPDH—osteoporosis	0.000809	0.00211	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PGLS—osteoporosis	0.000798	0.00208	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ANTXR2—osteoporosis	0.000798	0.00208	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—RAP1A—osteoporosis	0.000788	0.00206	CbGpPWpGaD
Pralatrexate—Vomiting—Estradiol—osteoporosis	0.000768	0.00134	CcSEcCtD
Pralatrexate—Rash—Estradiol—osteoporosis	0.000762	0.00133	CcSEcCtD
Pralatrexate—Dermatitis—Estradiol—osteoporosis	0.000761	0.00133	CcSEcCtD
Pralatrexate—FPGS—Disease—ENO1—osteoporosis	0.000761	0.00198	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PSMA5—osteoporosis	0.00075	0.00195	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PSMA2—osteoporosis	0.00075	0.00195	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ENO1—osteoporosis	0.000749	0.00195	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—MYC—osteoporosis	0.000749	0.00195	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KL—osteoporosis	0.000746	0.00195	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000746	0.00194	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PSMA2—osteoporosis	0.000738	0.00193	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PSMA5—osteoporosis	0.000738	0.00193	CbGpPWpGaD
Pralatrexate—Nausea—Estradiol—osteoporosis	0.000718	0.00125	CcSEcCtD
Pralatrexate—DHFR—Metabolism—PKM—osteoporosis	0.000705	0.00184	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—FDPS—osteoporosis	0.000705	0.00184	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—IL6—osteoporosis	0.000699	0.00182	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CALCA—osteoporosis	0.000699	0.00182	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000683	0.00178	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000683	0.00178	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GSN—osteoporosis	0.000679	0.00177	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.00067	0.00175	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PGLS—osteoporosis	0.000669	0.00174	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GPD2—osteoporosis	0.000669	0.00174	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000667	0.00174	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000651	0.0017	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ENO1—osteoporosis	0.000637	0.00166	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KL—osteoporosis	0.000634	0.00165	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PSMA2—osteoporosis	0.000628	0.00164	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PSMA5—osteoporosis	0.000628	0.00164	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—MYC—osteoporosis	0.000623	0.00162	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PKM—osteoporosis	0.000615	0.0016	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—FDPS—osteoporosis	0.000615	0.0016	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PNP—osteoporosis	0.000611	0.00159	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ATIC—osteoporosis	0.000611	0.00159	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PSMA5—osteoporosis	0.00061	0.00159	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PSMA2—osteoporosis	0.00061	0.00159	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP19A1—osteoporosis	0.000599	0.00156	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000596	0.00155	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000596	0.00155	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LRP5—osteoporosis	0.00059	0.00154	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ADCY5—osteoporosis	0.000584	0.00152	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GPD2—osteoporosis	0.000583	0.00152	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PGLS—osteoporosis	0.000583	0.00152	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000577	0.0015	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LRP6—osteoporosis	0.000565	0.00147	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—MYC—osteoporosis	0.000543	0.00142	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPL24—osteoporosis	0.000543	0.00141	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LTF—osteoporosis	0.000543	0.00141	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MTHFR—osteoporosis	0.000538	0.0014	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PNP—osteoporosis	0.000534	0.00139	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ATIC—osteoporosis	0.000534	0.00139	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PSMA5—osteoporosis	0.000533	0.00139	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PSMA2—osteoporosis	0.000533	0.00139	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000525	0.00137	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CA2—osteoporosis	0.00052	0.00136	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—OXCT1—osteoporosis	0.00052	0.00136	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IRS2—osteoporosis	0.000511	0.00133	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP19A1—osteoporosis	0.000509	0.00133	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MGLL—osteoporosis	0.000507	0.00132	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ADCY5—osteoporosis	0.000497	0.0013	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ADCY5—osteoporosis	0.000489	0.00128	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GPX1—osteoporosis	0.000488	0.00127	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ACP5—osteoporosis	0.00047	0.00123	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000458	0.00119	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTHFR—osteoporosis	0.000457	0.00119	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—OXCT1—osteoporosis	0.000454	0.00118	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA2—osteoporosis	0.000454	0.00118	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—MTHFR—osteoporosis	0.00045	0.00117	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IRS1—osteoporosis	0.000446	0.00116	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MGLL—osteoporosis	0.000442	0.00115	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TPI1—osteoporosis	0.000437	0.00114	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IRS2—osteoporosis	0.000435	0.00113	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—IDH2—osteoporosis	0.000431	0.00112	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6R—osteoporosis	0.000419	0.00109	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ADCY5—osteoporosis	0.000416	0.00109	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GPX1—osteoporosis	0.000415	0.00108	CbGpPWpGaD
Pralatrexate—DHFR—Disease—P4HB—osteoporosis	0.000411	0.00107	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP27A1—osteoporosis	0.000405	0.00106	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GAPDH—osteoporosis	0.000404	0.00105	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ACP5—osteoporosis	0.000394	0.00103	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NFATC1—osteoporosis	0.000384	0.001	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—MTHFR—osteoporosis	0.000383	0.000998	CbGpPWpGaD
Pralatrexate—DHFR—Disease—DKK1—osteoporosis	0.000381	0.000992	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IRS1—osteoporosis	0.00038	0.00099	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—IDH2—osteoporosis	0.000376	0.00098	CbGpPWpGaD
Pralatrexate—DHFR—Disease—WNT1—osteoporosis	0.000367	0.000956	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TPI1—osteoporosis	0.000366	0.000955	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—POMC—osteoporosis	0.00036	0.000939	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGA—osteoporosis	0.000357	0.00093	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6R—osteoporosis	0.000357	0.00093	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP27A1—osteoporosis	0.000353	0.000922	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000347	0.000904	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000346	0.000902	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—P4HB—osteoporosis	0.000344	0.000898	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ACP5—osteoporosis	0.000344	0.000897	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GAPDH—osteoporosis	0.000338	0.000881	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—RAP1A—osteoporosis	0.000329	0.000859	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000323	0.000842	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—TPI1—osteoporosis	0.00032	0.000833	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ENO1—osteoporosis	0.000318	0.000829	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PSMA2—osteoporosis	0.000313	0.000817	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PSMA5—osteoporosis	0.000313	0.000817	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—POMC—osteoporosis	0.000306	0.000798	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—P4HB—osteoporosis	0.000301	0.000784	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GAPDH—osteoporosis	0.000295	0.000769	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CALCA—osteoporosis	0.000292	0.000761	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—RAP1A—osteoporosis	0.000287	0.000749	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ENO1—osteoporosis	0.000266	0.000694	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KL—osteoporosis	0.000265	0.000691	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PSMA5—osteoporosis	0.000262	0.000684	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PSMA2—osteoporosis	0.000262	0.000684	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—osteoporosis	0.00025	0.000653	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—osteoporosis	0.000248	0.000648	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—osteoporosis	0.000248	0.000646	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ENO1—osteoporosis	0.000232	0.000606	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PSMA2—osteoporosis	0.000229	0.000597	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PSMA5—osteoporosis	0.000229	0.000597	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP19A1—osteoporosis	0.000213	0.000555	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—osteoporosis	0.000211	0.000551	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—osteoporosis	0.000211	0.00055	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ADCY5—osteoporosis	0.000208	0.000541	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—osteoporosis	0.000192	0.000502	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—osteoporosis	0.000191	0.000498	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—osteoporosis	0.000187	0.000487	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP19A1—osteoporosis	0.000186	0.000484	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IRS2—osteoporosis	0.000182	0.000474	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ADCY5—osteoporosis	0.000174	0.000453	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GPX1—osteoporosis	0.000173	0.000452	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—osteoporosis	0.000172	0.000449	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	0.000168	0.000438	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—osteoporosis	0.00016	0.000417	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—osteoporosis	0.000159	0.000414	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IRS1—osteoporosis	0.000159	0.000413	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADCY5—osteoporosis	0.000152	0.000396	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GPX1—osteoporosis	0.000151	0.000394	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—osteoporosis	0.00015	0.000391	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6R—osteoporosis	0.000149	0.000388	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—osteoporosis	0.00014	0.000364	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—POMC—osteoporosis	0.000128	0.000333	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—POMC—osteoporosis	0.000112	0.000291	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—osteoporosis	8.83e-05	0.00023	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—osteoporosis	8.8e-05	0.00023	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—osteoporosis	6.63e-05	0.000173	CbGpPWpGaD
